comparemela.com
Home
Live Updates
Igraine Plc - Audited Results to 31 December 2020 : comparem
Igraine Plc - Audited Results to 31 December 2020 : comparem
Igraine Plc - Audited Results to 31 December 2020
Igraine Plc - Audited Results to 31 December 2020 PR Newswire London, December 22 IGRAINE PLC AQSE: KING ("Igraine" or the "Company") Audited Final Results
Related Keywords
United Kingdom ,
Zurich ,
Züsz ,
Switzerland ,
Camborne ,
Cornwall ,
United States ,
London ,
City Of ,
American ,
Swiss ,
John Martin ,
Chris Evans ,
Martin Walton ,
Ramsay Smith ,
Miller Mark Anwyl ,
Burns Singh Tennent Bhohi ,
Arix Bioscience ,
Stephen Winfield ,
Simon Grant ,
Brian Jones ,
Stephen Steve David Winfield ,
Christopher Evans ,
Kenneth Hillen ,
Directors Of Igraine ,
Rio Tinto ,
Simbec Orion Group ,
Market Of The London Stock Exchange ,
Exchange Growth Market ,
Astrazeneca ,
Facebook ,
X Markets Group Limited ,
Excalibur Healthcare Services ,
Shareholders The Company ,
Board Of Igraine ,
Merlin Biosciences Ltd ,
Iota Sciences Ltd ,
Group United Kingdom ,
Excalibur Medicines Ltd ,
Rapid Nutrition Plc ,
Just Bee Drinks Limited ,
Ellipses Pharma ,
Excalibur Healthcare Services Ltd ,
Glenpani Group ,
Bradshaw Consulting Ltd ,
Directors Of The Company ,
Twitter ,
Excalibur Fund Managers Life Sciences ,
Excalibur Group ,
Arthurian Life Sciences Ltd ,
Merlin Ventures ,
Asset Capital Ltd ,
Peterhouse Capital ,
Oxford University ,
Globe Capital Ltd ,
Economics Social Sciences ,
Chiroscience ,
Wales Life Sciences Investment Fund ,
Sosei Co ,
Igraine Plc ,
University Of Glasgow ,
Swiss Exchange ,
Biotech Growth ,
Media House International ,
Camborne School Of Mines Bsc Mining Engineering ,
Biovex Group Inc ,
Piramed Limited To Roche Group ,
Amgen Inc ,
Just Bee Drinks Ltd ,
Forum Energy Metals Corp ,
Final Results ,
Access Segment ,
Growth Market ,
Non Executive Chairman ,
London Stock Exchange ,
Directors Post Year End Review ,
Following Meetings ,
Apple Wallet ,
Google Pay ,
Wallet Ads ,
One Media ,
Just Bee ,
Just Bee Drinks ,
Year Ending ,
Annual General Meeting ,
General Meeting ,
Peterhouse Capital Limited ,
Corporate Advisor ,
Professor Christopher Evans ,
Sir Christopher Evans ,
Merlin Biosciences Funds ,
Biovex Group ,
Piramed Limited ,
Through Merlin Ventures Limited ,
Biotech Growth Trust ,
Merlin Biosciences ,
Ellipses Pharma Limited ,
Professor Sir Christopher Evans ,
Scoffs Group ,
Costa Coffee ,
Strategic Advisory ,
Interrad Medical ,
Minneapolis Based Medtech ,
Vice Chairman ,
Executive Chairman ,
Professor Sir Chris Evans ,
Excalibur Fund Managers ,
Life Sciences ,
Singh Tennent Bhohi ,
Forum Energy Metals ,
Janice Lake ,
North American ,
Camborne School ,
Mining Engineering ,
Falconbridge Internationals ,
Management Roles ,
All Active Asset Capital Ltd ,
Globe Capital ,
Quetzal Capital ,
New Investment ,
Co Investment Agreement ,
Executive Team ,
Investigational New Drug ,
New Drug Applications ,
Co Investment Rights ,
Excalibur Healthcare ,
Deferred Shares ,
These Deferred Shares ,
Potential Therapy ,
George Street Capital ,
United Kingdom Based ,
Serious Adverse Events ,
Treatment Emergent Adverse Events ,
Excalibur Medicines ,
Sir Chris ,
Professor John Martin ,
Executive Director ,
Market Corporate ,
Media House ,
Migraine ,
Udited ,
Results ,
December ,
020 ,